Home > Boards > US Listed > Biotechs > METACRINE (MTCR)

Metacrine shares are trading higher after the company

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
crudeoil24 Member Profile
Member Level 
Followed By 688
Posts 46,262
Boards Moderated 6
Alias Born 12/12/04
160x600 placeholder
Metacrine and Its Partners to Present Data at the EASL International Liver Congress™ 2021 GlobeNewswire Inc. - 6/17/2021 8:05:00 AM
Metacrine initiated buy at H.C. Wainwright citing novelty in therapeutic platform Seeking Alpha - 6/14/2021 12:30:43 PM
Metacrine Achieves Full Enrollment for MET409 Phase 2a Combination Trial in Patients With Type 2 Diabetes and NASH GlobeNewswire Inc. - 6/2/2021 8:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/26/2021 4:31:05 PM
Metacrine to Present at 2021 Jefferies Healthcare Conference GlobeNewswire Inc. - 5/26/2021 8:05:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/25/2021 7:03:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/25/2021 7:01:40 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/25/2021 7:00:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/25/2021 6:59:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/25/2021 6:58:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/25/2021 6:56:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/25/2021 6:56:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/25/2021 6:55:23 PM
Metracrine rises 10.27% after hours as CMO and CEO acquires shares Seeking Alpha - 5/21/2021 5:30:44 AM
Metacrine to Present New Preclinical Data on MET642 in Inflammatory Bowel Disease at Digestive Disease Week 2021 Virtual Meet... GlobeNewswire Inc. - 5/19/2021 8:05:00 AM
Metacrine Achieves Enrollment Target for MET642 Phase 2a Trial Interim Analysis GlobeNewswire Inc. - 5/18/2021 8:05:00 AM
Metacrine reports Q1 results Seeking Alpha - 5/13/2021 5:31:36 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/13/2021 4:18:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/13/2021 4:11:33 PM
Metacrine Accelerates MET409 Clinical Development Milestone and Reports First-Quarter 2021 Results GlobeNewswire Inc. - 5/13/2021 4:05:00 PM
Metacrine to Present at 2021 RBC Global Healthcare Conference GlobeNewswire Inc. - 5/11/2021 8:05:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/7/2021 6:37:36 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/9/2021 4:11:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/5/2021 4:11:00 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/5/2021 4:10:54 PM
crudeoil24 Member Level  Monday, 10/12/20 08:54:42 AM
Re: crudeoil24 post# 1
Post # of 11 
Metacrine shares are trading higher after the company announced it is presenting new data from its MET409 program in NASH at AASLD's The Liver Meeting Digital Experience.

New York Yankees and Duke Basketball
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences